{"id":138888,"date":"2026-05-08T08:51:40","date_gmt":"2026-05-08T08:51:40","guid":{"rendered":"https:\/\/indogenmed.org\/product\/tobracid-dm-3-gm-tablets\/"},"modified":"2026-08-27T19:30:55","modified_gmt":"2026-08-27T19:30:55","slug":"tobracid-dm-3-gm-tablets","status":"publish","type":"product","link":"https:\/\/indogenmed.org\/ja\/product\/tobracid-dm-3-gm-tablets\/","title":{"rendered":"Tobracid Dm 3 Gm"},"content":{"rendered":"

Tobracid Dm 3 Gm Tablets (Tobramycin 0.3% & Dexamethasone 0.1% w\/w Ophthalmic Ointment): Clinical Profile, Uses, Dosage, and Safety<\/h1>\n

Tobracid Dm 3 Gm Tablets<\/strong> is a prescription product containing Tobramycin 0.3% & Dexamethasone 0.1% w\/w Ophthalmic Ointment<\/strong>. It is used in clinically selected treatment pathways and should be used only under professional supervision. This page summarizes core product facts to support informed discussions with licensed healthcare professionals.<\/p>\n

Safe use depends on diagnosis, formulation, route, dose, and duration. For this reason, the sections below provide a structured profile aligned with clinical documentation standards for pharmaceutical education.<\/p>\n

Introduction<\/h2>\n

Tobracid Dm 3 Gm Tablets is a ophthalmic solution manufactured by Entod Pharmaceuticals Ltd . Specifically designed for the management of steroid-r<\/strong>. It is commonly positioned within the antibiotic class and is typically prescribed for clearly defined therapeutic use cases. While product names are familiar to patients, treatment decisions should always be guided by clinical evaluation and official labeling.<\/p>\n

Patients should verify product identity, strength, and route every time a medicine is dispensed. Similar-looking brand names can represent different active ingredients, and substitutions should only be made with clinician or pharmacist confirmation.<\/p>\n

1. Product Overview \/ Clinical Profile<\/h2>\n
    \n
  • Brand Name:<\/strong> Tobracid Dm 3 Gm Tablets<\/li>\n
  • Active Ingredient:<\/strong> Tobramycin 0.3% & Dexamethasone 0.1% w\/w Ophthalmic Ointment<\/li>\n
  • Manufacturer:<\/strong> Entod Pharmaceuticals Ltd . Specifically designed for the management of steroid-r<\/li>\n
  • Dosage Form:<\/strong> ophthalmic solution<\/li>\n
  • Therapeutic Category:<\/strong> antibiotic<\/li>\n<\/ul>\n

    2. Mechanism of Action (MOA)<\/h2>\n

    Tobracid Dm 3 Gm Tablets acts through Tobramycin 0.3% & Dexamethasone 0.1% w\/w Ophthalmic Ointment, an antibacterial mechanism that inhibits critical microbial growth pathways and supports clearance of susceptible infections when used at the prescribed dose and duration.<\/p>\n

    Mechanistic understanding helps explain prescribing rationale, expected response timelines, and monitoring requirements. For antimicrobials, susceptibility patterns and resistance risk are central. For ocular pressure therapies, durable adherence and pressure control trends matter more than short-term symptom fluctuations. For anti-inflammatory and other chronic-use medicines, risk-benefit is reassessed through follow-up.<\/p>\n

    MOA should always be interpreted in context: pharmacology defines potential effect, but real-world response depends on diagnosis quality, adherence, interacting medicines, and patient-specific comorbid conditions.<\/p>\n

    3. Therapeutic Indications<\/h2>\n

    Tobracid Dm 3 Gm Tablets is typically used for bacterial conjunctivitis and related susceptible ocular infections. Final indication should match local labeling, clinician judgement, and patient-specific risk profile.<\/p>\n

      \n
    • Use only for the indication selected by a licensed prescriber.<\/li>\n
    • Avoid self-initiating or extending treatment duration without clinical review.<\/li>\n
    • Reassessment is needed if expected improvement does not occur.<\/li>\n<\/ul>\n

      Clinical teams often adjust treatment based on severity, prior therapy exposure, and response monitoring. The objective is to achieve therapeutic benefit while minimizing avoidable adverse events.<\/p>\n

      4. Dosage and Administration<\/h2>\n

      General dosing guidance: 3 mg (0, or as directed by the prescriber.<\/p>\n

      Exact schedules vary by diagnosis and patient profile. Prescribed instructions on label frequency, duration, and technique should be followed precisely.<\/p>\n

        \n
      • Use exactly as directed by the prescriber.<\/li>\n
      • Do not skip doses or double up missed doses unless advised.<\/li>\n
      • If ophthalmic, avoid touching the dropper\/tube tip to any surface.<\/li>\n
      • If injectable, follow sterile handling and storage requirements.<\/li>\n
      • Ask the clinician for written missed-dose guidance at initiation.<\/li>\n<\/ul>\n

        Administration quality can materially affect outcomes. Correct timing, route, and storage are often as important as selecting the correct medicine class.<\/p>\n

        5. Safety Profile and Precautions<\/h2>\n

        \u526f\u4f5c\u7528\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306f\u3001\u6709\u52b9\u6210\u5206\u3084\u85ac\u5264\u30af\u30e9\u30b9\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3059\u3002\u60a3\u8005\u306f\u3001\u4f7f\u7528\u524d\u306b\u7981\u5fcc\u4e8b\u9805\u3001\u30a2\u30ec\u30eb\u30ae\u30fc\u6b74\u3001\u81d3\u5668\u6a5f\u80fd\u4e0a\u306e\u61f8\u5ff5\u4e8b\u9805\u3001\u76f8\u4e92\u4f5c\u7528\u30ea\u30b9\u30af\u3092\u78ba\u8a8d\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u6301\u7d9a\u7684\u3001\u91cd\u5ea6\u3001\u307e\u305f\u306f\u4e88\u671f\u3057\u306a\u3044\u75c7\u72b6\u304c\u3042\u308b\u5834\u5408\u306f\u3001\u901f\u3084\u304b\u306b\u533b\u7642\u6a5f\u95a2\u306b\u76f8\u8ac7\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n

        \u91cd\u8981\u306a\u6ce8\u610f\u4e8b\u9805\u306b\u306f\u3001\u51e6\u65b9\u3055\u308c\u305f\u671f\u9593\u306b\u5f93\u3046\u3053\u3068\u3001\u533b\u5e2b\u306e\u6307\u5c0e\u306a\u3057\u306b\u7528\u91cf\u3092\u5897\u52a0\u3055\u305b\u306a\u3044\u3053\u3068\u3001\u304a\u3088\u3073\u52b9\u679c\u4e0d\u8db3\u306e\u5834\u5408\u306f\u65e9\u671f\u306b\u5831\u544a\u3059\u308b\u3053\u3068\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u773c\u79d1\u88fd\u5264\u306e\u5834\u5408\u3001\u885b\u751f\u7ba1\u7406\u3068\u6c5a\u67d3\u9632\u6b62\u304c\u7279\u306b\u91cd\u8981\u3067\u3059\u3002\u5168\u8eab\u6027\u85ac\u5264\u306e\u5834\u5408\u3001\u30ea\u30b9\u30af\u56e0\u5b50\u306b\u5fdc\u3058\u3066\u81e8\u5e8a\u533b\u306f\u691c\u67fb\u3092\u8981\u3059\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n

        \u91cd\u5ea6\u306e\u904e\u654f\u75c7\u53cd\u5fdc\u3001\u547c\u5438\u56f0\u96e3\u3001\u5f90\u3005\u306b\u9032\u884c\u3059\u308b\u816b\u308c\u3001\u6025\u6fc0\u306a\u8996\u529b\u5909\u5316\u3001\u307e\u305f\u306f\u305d\u306e\u4ed6\u306e\u6025\u6027\u60aa\u5316\u306e\u5146\u5019\u304c\u3042\u308b\u5834\u5408\u306f\u3001\u76f4\u3061\u306b\u7dca\u6025\u533b\u7642\u3092\u6c42\u3081\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n

        \u4fdd\u7ba1\u3068\u53d6\u308a\u6271\u3044<\/h2>\n

        \u88fd\u54c1\u30e9\u30d9\u30eb\u306b\u5f93\u3063\u3066\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u85ac\u54c1\u306f\u5143\u306e\u5bb9\u5668\u306b\u5165\u308c\u305f\u307e\u307e\u3001\u71b1\u3084\u6e7f\u6c17\u306e\u306a\u3044\u5834\u6240\u306b\u4fdd\u7ba1\u3057\u3001\u5b50\u4f9b\u306e\u624b\u306e\u5c4a\u304b\u306a\u3044\u5834\u6240\u306b\u7f6e\u3044\u3066\u304f\u3060\u3055\u3044\u3002\u773c\u79d1\u88fd\u5264\u306f\u5e38\u306b\u30ad\u30e3\u30c3\u30d7\u3092\u9589\u3081\u3001\u6c5a\u67d3\u3092\u9632\u304e\u307e\u3059\u3002\u6ce8\u5c04\u5264\u306f\u53b3\u683c\u306a\u6e29\u5ea6\u7ba1\u7406\u304c\u5fc5\u8981\u306a\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n

        \u671f\u9650\u5207\u308c\u307e\u305f\u306f\u640d\u50b7\u3057\u305f\u88fd\u54c1\u306f\u4f7f\u7528\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u5bb9\u5668\u306b\u640d\u50b7\u304c\u3042\u308b\u5834\u5408\u306f\u3001\u85ac\u5264\u5e2b\u307e\u305f\u306f\u533b\u7642\u5f93\u4e8b\u8005\u304c\u9069\u5207\u306a\u4f7f\u7528\u53ef\u5426\u3092\u78ba\u8a8d\u3059\u308b\u307e\u3067\u4f7f\u7528\u3092\u5ef6\u671f\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n

        \u81e8\u5e8a\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u3068\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u30dd\u30a4\u30f3\u30c8<\/h2>\n

        \u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u3067\u306f\u3001\u81e8\u5e8a\u7684\u306a\u53cd\u5fdc\u3001\u8010\u5bb9\u6027\u3001\u670d\u85ac\u9075\u5b88\u72b6\u6cc1\u3092\u8a55\u4fa1\u3057\u307e\u3059\u3002\u60a3\u8005\u306b\u306f\u3001\u85ac\u5264\u30ea\u30b9\u30c8\u3092\u4fdd\u6301\u3057\u3001\u5e02\u8ca9\u85ac\u306e\u4f7f\u7528\u3092\u5831\u544a\u3057\u3001\u6cbb\u7642\u5909\u66f4\u3092\u533b\u7642\u6a5f\u95a2\u9593\u3067\u5171\u6709\u3059\u308b\u3088\u3046\u4fc3\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u3067\u306f\u3001\u672c\u60c5\u5831\u306f\u6559\u80b2\u76ee\u7684\u3067\u3042\u308a\u3001\u500b\u5225\u8a3a\u65ad\u306b\u4ee3\u308f\u308b\u3082\u306e\u3067\u306f\u306a\u3044\u3053\u3068\u3092\u5f37\u8abf\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n

        \u5fc5\u8981\u306b\u5fdc\u3058\u3066\u3001\u533b\u7642\u5f93\u4e8b\u8005\u306f\u5730\u57df\u306e\u6297\u83cc\u85ac\u7ba1\u7406\u3001\u6162\u6027\u75be\u60a3\u30d7\u30ed\u30c8\u30b3\u30eb\u3001\u307e\u305f\u306f\u5c02\u9580\u5206\u91ce\u306e\u7d4c\u8def\u306b\u6cbf\u3063\u3066\u6cbb\u7642\u3092\u8abf\u6574\u3057\u3001\u52b9\u679c\u3092\u7dad\u6301\u3057\u3001\u56de\u907f\u53ef\u80fd\u306a\u30ea\u30b9\u30af\u3092\u4f4e\u6e1b\u3057\u307e\u3059\u3002<\/p>\n

        \u533b\u7642\u4e0a\u306e\u6ce8\u610f:<\/strong> \u672c\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u60c5\u5831\u63d0\u4f9b\u76ee\u7684\u306e\u307f\u3067\u3059\u3002\u81ea\u5df1\u6295\u85ac\u306f\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u8a3a\u65ad\u3084\u6cbb\u7642\u306b\u3064\u3044\u3066\u306f\u5fc5\u305a\u533b\u7642\u5c02\u9580\u5bb6\u306b\u3054\u76f8\u8ac7\u304f\u3060\u3055\u3044\u3002<\/div>\n","protected":false},"excerpt":{"rendered":"

        Tobracid Dm 3 Gm Tablets (Tobramycin 0.3% & Dexamethasone 0.1% w\/w Ophthalmic Ointment): Clinical Profile […]<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[11876],"product_cat":[11265],"product_tag":[15912,15911],"igm_manufacturer":[],"class_list":["post-138888","product","type-product","status-publish","product_brand-entod-pharmaceuticals-ltd","product_cat-glaucoma-ja","product_tag-strip","product_tag-tablet","pa_brand-name-tobracid-dm","pa_molecule-tobramycin","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product\/138888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/comments?post=138888"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/media?parent=138888"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_brand?post=138888"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_cat?post=138888"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_tag?post=138888"},{"taxonomy":"igm_manufacturer","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/igm_manufacturer?post=138888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}